T15282 |
Filibuvir
|
877130-28-4
|
99.68%
|
|
Filibuvir (PF-00868554) is a selective and noncovalent inhibitor of HCV NS5B RNA-dependent RNA polymerase. Filibuvir inhibits genotype 1a and 1b replicons with E...
|
TQ0162 |
R-1479
|
478182-28-4
|
99.68%
|
|
R-1479 (4'-Azidocytidine) is an RdRp inhibitor with an IC50 value of 1.28 μM for HCV RNA replication in the HCV subgenomic replicon system.
|
T11539 |
HCV-IN-29
|
1009119-83-8
|
99.66%
|
|
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
|
T3489 |
Dasabuvir
|
1132935-63-7
|
99.62%
|
|
Dasabuvir (ABT-333) is a non-nucleoside inhibitor of the hepatitis C virus (HCV) non-structural protein 5B (NS5B), an RNA-dependent RNA polymerase, with potentia...
|
T3226 |
Paritaprevir
|
1221573-85-8
|
99.57%
|
|
Paritaprevir (ABT-450) is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural...
|
T6025 |
Danoprevir
|
850876-88-9
|
99.52%
|
|
Danoprevir (RG7227) is a peptidomimetic inhibitor of the NS3/4A protease(IC50=0.2-3.5 nM) of hepatitis C virus (HCV).
|
T67788 |
BAY-43-9695
|
233255-39-5
|
99.51%
|
|
BAY-43-9695 is a non-nucleoside compound with anti-human cytomegalovirus (HCMV) activity. It is the major metabolite of BAY-38-4766.
|
T2774 |
Lycorine hydrochloride
|
2188-68-3
|
99.49%
|
|
Lycorine hydrochloride (Narcissine hydrochloride) is VE-cadherin inhibitor,and has IC50 of 1.2μM in Hey1B cell.It is an HCV inhibitor with strong activity.
|
T11760 |
KIN101
|
610753-87-2
|
99.46%
|
|
KIN101 (3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene), an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KI...
|
T21537L |
TMC647055 Choline Hydroxide Salt
|
T21537L
|
99.44%
|
|
TMC647055 Choline Hydroxide Salt is a novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase which potentially for the treatment of HCV infection. ...
|
T16088 |
MK-0608
|
443642-29-3
|
99.42%
|
|
MK-0608 is an orally bioavailable HCV replication inhibitor in vitro(EC50 = 0.3 μM and EC90=1.3 μM in the subgenomic-replicon assay).
|
T14489 |
Azvudine
|
1011529-10-4
|
99.42%
|
|
Azvudine (FNC) is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine inhibits NRTI-resistant viral...
|
T7607 |
PSI-6130
|
817204-33-4
|
99.36%
|
|
PSI-6130 (R 1656) is a potent and selective HCV NS5B polymerase inhibitor. PSI-6130 inhibits HCV replication with a mean IC50 of 0.6 μM.
|
T4547 |
Grazoprevir
|
1350514-68-9
|
99.36%
|
|
Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 ...
|
T2117 |
PSI-6206
|
863329-66-2
|
99.33%
|
|
PSI-6206 (RO 2433) (RO2433) is a selective HCV RNA polymerase inhibitor.
|
T27586 |
IDX184
|
1036915-08-8
|
99.29%
|
|
IDX184 is a potent, orally active, targeted HCV polymerase inhibitor and nucleoside polymerase.IDX184 effectively inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 ...
|
T26815 |
BILB-1941
|
494856-61-0
|
99.24%
|
|
BILB-1941 (BILB-1941ZW) is an inhibitor of HCV NS5B polymerase and can be used in studies about HCV infection.
|
TQ0122L |
VCH-916 free acid(1200133-34-1 free base)
|
914778-92-0
|
99.19%
|
|
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
|
T4988 |
Boceprevir
|
394730-60-0
|
99.16%
|
|
Boceprevir (SCH 503034) is a novel, potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with Ki of 14 nM in both enzyme assay and EC90 of 35...
|
T5126 |
Glecaprevir
|
1365970-03-1
|
99.16%
|
|
Glecaprevir (ABT-493) is an HCV NS3/4A protease inhibitor, (IC50s: 3.5-11.3 nM).
|